1
Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrome (TRISTAN)
Condition(s):Hypertriglyceridemia; Metabolic SyndromeLast Updated:December 15, 2021Completed
Tricor: 242 Clinical Trials, Page 1 of 25
Hide Studies Not Open or Pending
2
Effects of Fenofibrate Therapy in Diabetic Nephropathy
Condition(s):Diabetes Mellitus; Diabetic NephropathiesLast Updated:December 14, 2020Recruiting
3
Cardiovascular, Pulmonary, and Integrative Functional Phenotypes in COVID-19 Survivors – Effect of Fenofibrate
Condition(s):Covid19Last Updated:October 15, 2021Recruiting
4
Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:June 14, 2017Terminated
5
Bioequivalence Study of Fenofibric Acid Versus Tricor® (Fenofibrate)
Condition(s):HealthyLast Updated:November 3, 2009Completed
6
Fed Bioequivalence Study of Fenofibric Acid Versus TriCor® (Fenofibrate)
Condition(s):HealthyLast Updated:October 20, 2009Completed
7
Evaluate the Efficacy of Fenofibrate on Microalbuminuria
Condition(s):MicroalbuminuriaLast Updated:December 11, 2014Unknown status
8
The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans
Condition(s):HypertensionLast Updated:June 28, 2013Completed
9
Fenofibrate in Type 2 Diabetes
Condition(s):Diabetes Mellitus, Type IILast Updated:February 8, 2022Completed
10
Fenofibrate and Pharmacogenetic Impact in Dyslipidemia
Condition(s):DyslipidemiaLast Updated:January 13, 2020Completed